Vanguard Group
IDIX

Vanguard Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Vanguard Group’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,184,612
Closed -$173M – 4045
2014
Q2 		$173M Sell
7,184,612
-332,117
-4% -$3.46M 0.01% 1051
2014
Q1 		$45.3M Buy
7,516,729
+1,271,835
+20% +$8.87M ﹤0.01% 1859
2013
Q4 		$37.3M Buy
6,244,894
+204,940
+3% +$948K ﹤0.01% 1922
2013
Q3 		$31.5M Buy
6,039,954
+168,504
+3% +$738K ﹤0.01% 1950
2013
Q2 		$21.2M Buy
+5,871,450
New +$24M ﹤0.01% 2057

Vanguard Group's IDIX Position: Q3 2014 in Review

Vanguard Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 7,184,612 shares — an estimated $173M sold.

Vanguard Group first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $173M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Vanguard Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Vanguard Group sold 7,184,612 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $173M.
  • Vanguard Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Vanguard Group's IDENIX PHARMACEUTICALS INC position peaked at $173M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Vanguard Group's 13F filing for Q3 2014, filed 12 Nov 2014.